1 Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1–e60.
2 Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, et al.; AspICU Study Investigators. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56–64. Erratum in: Am J Respir Crit Care Med. 2012;186(8):808.
3 Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, et al.; Dutch-Belgian Mycosis study group. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10):782–92.
4 Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis. 2010;42(6–7):461–8.
5 Benedict K, Thompson GR 3rd, Jackson BR. Cannabis Use and Fungal Infections in a Commercially Insured Population, United States, 2016. Emerg Infect Dis. 2020;26(6):1308–10.
6 Jenks JD, Nam HH, Hoenigl M. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches. Mycoses. 2021;64(9):1002–14.
7 Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524–35.
8 Bassetti M, Peghin M, Vena A. Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review. Infect Dis Ther. 2018;7(1):17–27.
9 Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, et al. PREDICO Study Group. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis. 2021;73(11):e3606–e3614.